BINOY SHIVANNA to Lipopolysaccharides
This is a "connection" page, showing publications BINOY SHIVANNA has written about Lipopolysaccharides.
Connection Strength
2.247
-
Blocking IL-17a Signaling Decreases Lung Inflammation and Improves Alveolarization in Experimental Bronchopulmonary Dysplasia. Am J Pathol. 2024 11; 194(11):2023-2035.
Score: 0.765
-
Interactive and independent effects of early lipopolysaccharide and hyperoxia exposure on developing murine lungs. Am J Physiol Lung Cell Mol Physiol. 2020 12 01; 319(6):L981-L996.
Score: 0.584
-
Consequences of early postnatal lipopolysaccharide exposure on developing lungs in mice. Am J Physiol Lung Cell Mol Physiol. 2019 01 01; 316(1):L229-L244.
Score: 0.511
-
Leveraging Integrated RNA Sequencing to Decipher Adrenomedullin's Protective Mechanisms in Experimental Bronchopulmonary Dysplasia. Genes (Basel). 2024 Jun 19; 15(6).
Score: 0.190
-
Adrenomedullin Deficiency Potentiates Lipopolysaccharide-Induced Experimental Bronchopulmonary Dysplasia in Neonatal Mice. Am J Pathol. 2021 12; 191(12):2080-2090.
Score: 0.156
-
Metabolome and microbiome multi-omics integration from a murine lung inflammation model of bronchopulmonary dysplasia. Pediatr Res. 2022 12; 92(6):1580-1589.
Score: 0.041